Bevacizumab trials for Head and Neck Squamous Cell Carcinoma

All Bevacizumab trials · All Head and Neck Squamous Cell Carcinoma trials

Phase breakdown

Recruiting trials studying Bevacizumab for Head and Neck Squamous Cell Carcinoma

• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
  NCT06047379 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
  NCT06084481 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 54 locations
• Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
  NCT05005403 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 48 locations

Common questions

How many trials study Bevacizumab for Head and Neck Squamous Cell Carcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.